LAMEA Smart Insulin Pens Market Analysis (2017-2023)

  • ID: 4470052
  • Report
  • 85 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 4

FEATURED COMPANIES

  • Companion Medical Inc.
  • DIAMESCO
  • Digital Medics
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Insulet Corporation
  • MORE
The LAMEA Smart Insulin Pen market is expected to witness market growth of 12.4% CAGR during the forecast period (2017 - 2023). Smart insulin pens are used in delivering insulin externally, and as a result, offering better diabetes management system. Insulin pens have gained popularity in the recent years. The demand is due to rapidly rising number of diabetic patients, and cost-effectiveness of the smart insulin pens. In addition, the simple functioning and accurate delivery of appropriate dosing adds to the demand. Nevertheless, some limitations prevail that limit the market growth, such as such as two types of insulin cannot be mixed in an insulin pen, therefore, leading more number of injections.

Diabetes is a major health condition that is rapidly growing among the world population; therefore, the adoption of smart insulin pens is vital for a safe and effective administration of insulin to people suffering from Diabetes. The major factors that drive the growth of the market include growing diabetic population, lower cost of insulin pumps, and painless injections. The other benefit of the device is that, it can be easily used by people with visual or motor skills impairments, which adds to the market growth. Additionally, demand for personalized or patient centric devices and need for limiting needle stick injury are the factors that add to the market expansion during the forecast period. The blood sugar control is the most challenging aspect nevertheless and security concern is still a restraining factor for the market growth.

Based on type, the market report segments the market into First Generation Pens and Second Generation Pens. Second Generation Pens further sub segmented into Bluetooth-Enabled and USB Connected. The End User covered under the report includes Hospitals & Clinics, Ambulatory Surgical Centers, and Home Care Settings. Based on usability, the market is segmented into prefilled insulin pens and reusable insulin pen. The report also covers country wise segmentation of Smart Insulin Pen market. The countries included in the report are Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the LAMEA Smart Insulin Pen Market. Key companies profiled in the report Companion Medical Inc, Digital Medics Ptd Ltd, Eli Lilly and Company, Novo Nordisk A/S, DIAMESCO, F. Hoffmann-La Roche AG, Insulet Corporation, CardioComm Solutions, Inc., Emperra GmbH E-Health Technologies, and Jiangsu Delfu medical device Co.,Ltd.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Companion Medical Inc.
  • DIAMESCO
  • Digital Medics
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Insulet Corporation
  • MORE
1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Smart Insulin Pen Market, by Type
1.4.2 LAMEA Smart Insulin Pen Market, by Usability
1.4.3 LAMEA Smart Insulin Pen Market, by End User
1.4.4 LAMEA Smart Insulin Pen Market, by Country
1.5 Methodology for the research

2. Market Overview
2.1 Introduction
2.2 Drivers, Restraints and Opportunities
2.2.1 Market Drivers
2.2.2 Market Restraints

3. LAMEA Smart Insulin Pen Market
3.1 LAMEA Smart Insulin Pen Market by Product
3.1.1 LAMEA Second Generation Smart Insulin Pen by Country
3.1.2 LAMEA Second Generation Smart Insulin Pen by Type
3.1.2.1 LAMEA Bluetooth-Enabled Smart Insulin Pen Market by Country
3.1.2.2 LAMEA USB Connected Smart Insulin Pen Market by Country
3.1.3 LAMEA First Generation Smart Insulin Pen by Country

4. LAMEA Smart Insulin Pen Market by Usability
4.1 Introduction
4.1.1 LAMEA Reusable Smart Insulin Pen by Usability Market by Country
4.1.2 LAMEA Prefilled Smart Insulin Pen by Usability Market by Country

5. LAMEA Smart Insulin Pen Market by End User
5.1 Introduction
5.1.1 LAMEA Hospitals & Clinics Smart Insulin Pen Market by Country
5.1.2 LAMEA Ambulatory Surgical Centers Smart Insulin Pen Market by Country
5.1.3 LAMEA Home Care Settings Smart Insulin Pen Market by Country

6. LAMEA Smart Insulin Pen Market by Country
6.1 Brazil Smart Insulin Pen Market
6.1.1 Brazil Smart Insulin Pen Market by Product
6.1.1.1 Brazil Second Generation Smart Insulin Pen by Type
6.1.2 Brazil Smart Insulin Pen Market by Usability
6.1.3 Brazil Smart Insulin Pen Market by End User
6.2 Argentina Smart Insulin Pen Market
6.2.1 Argentina Smart Insulin Pen Market by Product
6.2.1.1 Argentina Second Generation Smart Insulin Pen by Type
6.2.2 Argentina Smart Insulin Pen Market by Usability
6.2.3 Argentina Smart Insulin Pen Market by End User
6.3 UAE Smart Insulin Pen Market
6.3.1 UAE Smart Insulin Pen Market by Product
6.3.1.1 UAE Second Generation Smart Insulin Pen by Type
6.3.2 UAE Smart Insulin Pen Market by Usability
6.3.3 UAE Smart Insulin Pen Market by End User
6.4 Saudi Arabia Smart Insulin Pen Market
6.4.1 Saudi Arabia Smart Insulin Pen Market by Product
6.4.1.1 Saudi Arabia Second Generation Smart Insulin Pen by Type
6.4.2 Saudi Arabia Smart Insulin Pen Market by Usability
6.4.3 Saudi Arabia Smart Insulin Pen Market by End User
6.5 South Africa Smart Insulin Pen Market
6.5.1 South Africa Smart Insulin Pen Market by Product
6.5.1.1 South Africa Second Generation Smart Insulin Pen by Type
6.5.2 South Africa Smart Insulin Pen Market by Usability
6.5.3 South Africa Smart Insulin Pen Market by End User
6.6 Nigeria Smart Insulin Pen Market
6.6.1 Nigeria Smart Insulin Pen Market by Product
6.6.1.1 Nigeria Second Generation Smart Insulin Pen by Type
6.6.2 Nigeria Smart Insulin Pen Market by Usability
6.6.3 Nigeria Smart Insulin Pen Market by End User
6.7 Rest of LAMEA Smart Insulin Pen Market
6.7.1 Rest of LAMEA Smart Insulin Pen Market by Product
6.7.1.1 Rest of LAMEA Second Generation Smart Insulin Pen by Type
6.7.2 Rest of LAMEA Smart Insulin Pen Market by Usability
6.7.3 Rest of LAMEA Smart Insulin Pen Market by End User

7. Company Profiles
7.1 Eli Lilly and Company
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.2 F. Hoffmann-La Roche Ltd
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.3 Companion Medical Inc.
7.3.1 Company Overview
7.4 Digital Medics
7.4.1 Company Overview
7.5 Novo Nordisk A/S
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.6 DIAMESCO
7.6.1 Company Overview
7.7 Insulet Corporation
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.8 CardioComm Solutions, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Emperra GmbH E-Health Technologies
7.9.1 Company Overview
7.1 Jiangsu Delfu medical device Co.,Ltd
7.10.1 Company Overview
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Companion Medical Inc.
  • Digital Medics
  • Novo Nordisk A/S
  • DIAMESCO
  • Insulet Corporation
  • CardioComm Solutions, Inc.
  • Emperra GmbH E-Health Technologies
  • Jiangsu Delfu medical device Co.,Ltd.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll